Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Burrows

Showing results (341-350 of 377) with videos related to

Pageof 38
Sort By:
Journal of Virology|June 15, 2004
Selection pressure-driven evolution of the Epstein-Barr virus-encoded oncogene LMP1 in virus isolates from Southeast AsiaJacqueline M Burrows, Lindell Bromham, Megan Woolfit, et al.
The Journal of Experimental Medicine|November 9, 2005
The immunogenicity of a viral cytotoxic T cell epitope is controlled by its MHC-bound conformationFleur E Tynan, Diah Elhassen, Anthony W Purcell, et al.
Nature Immunology|January 30, 2007
A T cell receptor flattens a bulged antigenic peptide presented by a major histocompatibility complex class I moleculeFleur E Tynan, Hugh H Reid, Lars Kjer-Nielsen, et al.
Gene Therapy|July 25, 2020
Sufficiency for inducible Caspase-9 safety switch in human pluripotent stem cells and disease cellsToshinobu Nishimura, Haojun Xu, Masayuki Iwasaki, et al.
Nature|June 23, 2012
Immune self-reactivity triggered by drug-modified HLA-peptide repertoirePatricia T Illing, Julian P Vivian, Nadine L Dudek, et al.
Scientific Reports|February 11, 2014
Molecular imprint of exposure to naturally occurring genetic variants of human cytomegalovirus on the T cell repertoireCorey Smith, Stephanie Gras, Rebekah M Brennan, et al.
Stem Cell Reports|September 1, 2015
A Safeguard System for Induced Pluripotent Stem Cell-Derived Rejuvenated T Cell TherapyMiki Ando, Toshinobu Nishimura, Satoshi Yamazaki, et al.
Plos Pathogens|December 3, 2010
Genetic and structural basis for selection of a ubiquitous T cell receptor deployed in Epstein-Barr virus infectionJohn J Miles, Anna M Bulek, David K Cole, et al.
The Journal of Experimental Medicine|January 14, 2009
Natural micropolymorphism in human leukocyte antigens provides a basis for genetic control of antigen recognitionJulia K Archbold, Whitney A Macdonald, Stephanie Gras, et al.
Immunity|May 24, 2001
A novel approach to antigen-specific deletion of CTL with minimal cellular activation using alpha3 domain mutants of MHC class I/peptide complexX N Xu, M A Purbhoo, N Chen, et al.
Pageof 38

Showing results (341-350 of 377) with videos related to

Sort By:
Pageof 38
Journal of Virology|June 15, 2004
Selection pressure-driven evolution of the Epstein-Barr virus-encoded oncogene LMP1 in virus isolates from Southeast AsiaJacqueline M Burrows, Lindell Bromham, Megan Woolfit, et al.
The Journal of Experimental Medicine|November 9, 2005
The immunogenicity of a viral cytotoxic T cell epitope is controlled by its MHC-bound conformationFleur E Tynan, Diah Elhassen, Anthony W Purcell, et al.
Nature Immunology|January 30, 2007
A T cell receptor flattens a bulged antigenic peptide presented by a major histocompatibility complex class I moleculeFleur E Tynan, Hugh H Reid, Lars Kjer-Nielsen, et al.
Gene Therapy|July 25, 2020
Sufficiency for inducible Caspase-9 safety switch in human pluripotent stem cells and disease cellsToshinobu Nishimura, Haojun Xu, Masayuki Iwasaki, et al.
Nature|June 23, 2012
Immune self-reactivity triggered by drug-modified HLA-peptide repertoirePatricia T Illing, Julian P Vivian, Nadine L Dudek, et al.
Scientific Reports|February 11, 2014
Molecular imprint of exposure to naturally occurring genetic variants of human cytomegalovirus on the T cell repertoireCorey Smith, Stephanie Gras, Rebekah M Brennan, et al.
Stem Cell Reports|September 1, 2015
A Safeguard System for Induced Pluripotent Stem Cell-Derived Rejuvenated T Cell TherapyMiki Ando, Toshinobu Nishimura, Satoshi Yamazaki, et al.
Plos Pathogens|December 3, 2010
Genetic and structural basis for selection of a ubiquitous T cell receptor deployed in Epstein-Barr virus infectionJohn J Miles, Anna M Bulek, David K Cole, et al.
The Journal of Experimental Medicine|January 14, 2009
Natural micropolymorphism in human leukocyte antigens provides a basis for genetic control of antigen recognitionJulia K Archbold, Whitney A Macdonald, Stephanie Gras, et al.
Immunity|May 24, 2001
A novel approach to antigen-specific deletion of CTL with minimal cellular activation using alpha3 domain mutants of MHC class I/peptide complexX N Xu, M A Purbhoo, N Chen, et al.
Pageof 38